Metranquil en es it fr

Metranquil Brand names, Metranquil Analogs

Metranquil Brand Names Mixture

  • No information avaliable

Metranquil Chemical_Formula


Metranquil RX_link

No information avaliable

Metranquil fda sheet

Metranquil msds (material safety sheet)

Metranquil Synthesis Reference

No information avaliable

Metranquil Molecular Weight

309.469 g/mol

Metranquil Melting Point

< 25 oC

Metranquil H2O Solubility

Soluble as HCl salt

Metranquil State


Metranquil LogP


Metranquil Dosage Forms

Tablets (oral, 1 mg)

Metranquil Indication

Used for the symptomatic treatment of parkinsonism.

Metranquil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Metranquil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Metranquil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Metranquil Patient Information

Metranquil Organisms Affected

Humans and other mammals